Supported by Research To Prevent Blindness, Inc., New York, New York, United States (DS) and Macula Foundation, Inc., New York, New York, United States (KBF, DS).
Disclosure: S.T. Garrity, None; D. Sarraf, Allergan (F), Amgen (C), Bayer (C), Genentech (F, C), Heidelberg (F), Novartis (C), Nuvelution (C), Optovue (F, C), Regeneron (F, C); K.B. Freund, Genentech/Roche (F), Optovue (C), Zeiss (C), Heidelberg Engineering (C), Novartis (C); S.R. Sadda, Allergan (F, C), Carl Zeiss Meditec (F), Genentech (F), Heidelberg (F, C), Iconic Therapeutics (C), Nidek (F), Novartis (C), Optos (F, C), Topcon (F, C), Thrombogenics (C), CenterVue (C), NightstaRx (C)